Inve US ▾
OSOSCR

Oscar Health (OSCR) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 6, 2026

Source: earnings call transcript

Executive summary

Oscar Health Q2 FY26 — Record Profitability and Raised Full-Year Outlook

Oscar Health delivered record profitability in the first half of 2026, driven by strong revenue growth, improved MLR, and significant SG&A efficiency gains. The company raised its full-year outlook, reflecting confidence in its operating performance and scalable technology platform, despite anticipated membership churn from CMS program integrity efforts. Management emphasized the long-term strength of the individual market and Oscar's role in driving innovation and consumer choice.

Highlights

5
  • Revenue grew 70% year-over-year to $4.9 billion in Q2 FY26.

  • Medical Loss Ratio (MLR) improved 12 points year-over-year to 79.2% in Q2 FY26.

  • SG&A expense ratio improved 450 basis points to a record low of 14.2% in Q2 FY26.

  • Earnings from operations increased by $619 million year-over-year to $389 million in Q2 FY26.

  • Net income reached $1 billion for the first half of FY26, with $362 million in Q2 FY26.

Concerns

2
  • Outpatient utilization was elevated through the first 6 months of the year, though overall utilization was moderately favorable.

  • Expectation of increasing membership churn in the back half of the year, potentially double the typical 1%-2% per month, due to CMS program integrity processes.

Guidance & targets

CategoryTargetConfidence
Full-year Earnings from Operations
$500 million to $700 million
high materiality
High
Full-year Total Revenues
$18.7 billion to $19 billion
high materiality
High
Full-year Medical Loss Ratio (MLR)
81.5% to 82.5%
high materiality
High
Full-year SG&A Expense Ratio
15.6% to 16.1%
medium materiality
High
Full-year Adjusted EBITDA
Roughly $115 million above earnings from operations
high materiality
High
Membership Churn
Closer to twice the typical 1%-2% per month
medium materiality
Medium
MLR Seasonal Pattern
Continue to trend higher quarterly
medium materiality
High
SG&A Ratio Seasonal Pattern
Fourth quarter will be the highest SG&A ratio on a percentage basis
low materiality
High
Risk Adjustment as % of Direct Premiums
20%
medium materiality
High

OSCR operating KPIs by quarter

OSCR operating KPIs stated on its earnings calls, by fiscal quarter
KPI Mar 2026 Q1 FY26This call Jun 2026 Q2 FY26Change vs prior quarter
Members
3.2M Oscar ended the first quarter with 3.2 million members, an increase of 56% year-over-year. Source: earnings call transcript
2.96M Oscar ended the second quarter with 2.96 million members, up 46% year-over-year. Source: earnings call transcript
-7.5%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

ProductTypeDetails
Oswell Agent Radiology Programlaunch
HelloMenolaunch

Deals & partnerships

ICHRAx Electronic Data Exchange (EDE) platform for ICHRA, inviting competitors to join.

ICHRAx is built off an ACA-approved, CMS-approved EDE. It provides the infrastructure for ICHRA, allowing Oscar and its competitors to offer plans. It aims to facilitate employer transition from defined benefit to defined contribution, addressing network coverage concerns by including all competitors on the platform.

Risks & headwinds

Elevated Outpatient Utilization H1 FY26

Elevated through the first 6 months of the year

Mitigation:Overall utilization is moderately favorable, and trends are stable. Management is monitoring and acting quickly on 'flares' or hotspots in utilization.

Increased Membership Churn due to CMS Program Integrity H2 FY26

Expected to be closer to twice the typical 1%-2% per month

Mitigation:This is primarily a timing shift from Q2, not impacting full-year revenue guidance. Oscar is actively reviewing CMS files and has baked the financial implications into its full-year guidance, not seeing it as a risk to the outlook.

Potential for Market Contraction Current

Total ACA membership down 12% YoY to 19.2 million

Mitigation:Oscar's pricing assumptions account for market contraction. Wakely's morbidity report suggests potential upside. Oscar is expanding into ICHRA and other markets to grow its total available market.

What to watch in Q3 FY26

MLR Trend

Q3 FY26
Current 79.2% in Q2 FY26
Target Continued quarterly increase as members burn through deductibles

Why it matters

The seasonal pattern of MLR is expected to trend higher in the second half, impacting full-year profitability. Verification will confirm if the expected seasonal pattern holds.

I would expect that that's going to continue to pick up into the second half as members burn through their deductibles. So MLR from the first 6 months, I would expect it to continue to trend higher quarterly and the seasonal patterns will look, I think, pretty similar to what we've seen historically.

Find out whether OSCR delivers this. Inve re-checks your case every morning.

Q&A highlights

Can you elaborate on elevated outpatient utilization and how you view the pace of utilization for the rest of the year?

Outpatient is elevated but not outsized, with other categories favorable. Overall trends are stable and reasonable, consistent with expectations for the year.

“And at this point, the trends are stable. And so the utilization looks very reasonable and is favorable to our -- to what we would expect it at this point in the year.”

asked by Andrew Mok · answered by Mark Bertolini

2 min read 5 chapters

Detailed narrative

Individual Market Trends and Policy Advocacy

Oscar Health views the individual market as vital and expanding, catering to entrepreneurs, gig workers, part-time employees, and early retirees. The company anticipates its role will grow as labor market shifts accelerate, driven by AI. Management advocates for policies that empower consumers to choose their healthcare, emphasizing portable coverage and experiences.

Despite a 12% year-over-year contraction in total ACA membership to 19.2 million, this trend is favorable to Oscar's pricing assumptions, suggesting continued consumer demand and potential upside to their outlook.

Technology and AI-Driven Efficiency

Oscar's scalable technology platform and AI initiatives are central to its strategy, driving operating leverage and margin expansion. The company piloted a radiology program with its Oswell Agent, which uses claims history to guide members to high-quality, cost-effective providers, resulting in 1 in 4 members choosing recommended sites and saving $75 per appointment.

AI is also deployed in claims processing, achieving 98.7% first-pass accuracy, and in medical economics to identify and act on cost signals early, particularly in pharmacy, expecting tens of millions in annual savings.

Risk Adjustment and Utilization Dynamics

The final 2025 CMS risk adjustment report was approximately $160 million favorable to first-quarter accruals, fully recognized in Q2. The first 2026 risk adjustment report (through April) showed market morbidity tracking favorably to pricing and Q1 accruals, though only a small portion was recognized due to early-stage data.

Year-to-date utilization was moderately favorable overall, with inpatient, professional, and pharmacy utilization favorable, while outpatient was elevated. Management expects MLR to trend higher in the second half due to seasonal patterns as members burn through deductibles.

ICHRA Expansion and Partnership Strategy

Oscar is building momentum in ICHRA (Individual Coverage Health Reimbursement Arrangement) with steady demand from small businesses in healthcare and professional services. The company launched ICHRAx, an Electronic Data Exchange (EDE) built off an ACA-approved platform, which allows Oscar and its competitors to offer plans to ICHRA members.

This platform enables employers to transition to defined contribution models, potentially saving up to 26% of costs, by providing access to a broad network of plans and reducing employer concerns about network coverage.

2027 Rate Cycle and Market Outlook

Management believes the 2027 rate cycle has been rational so far, with pricing decisions made on a market-by-market basis. They anticipate a rational pricing environment reflecting CMS' program integrity efforts. Oscar expects the ACA market enrollment to remain stable or grow in 2027, with opportunities to gain market share, particularly through ICHRA.

The company is prepared to adjust product and pricing if needed, especially concerning potential changes to the Notice of Benefit and Payment Parameters (NBPP).

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.